Coloplast announced today that it has completed the acquisition of Nine Continents Medical, Inc., an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active ...
Coloplast is the market leader with an estimated 38% share; privately held competitors Hollister and ConvaTec roughly split the rest of the market. Although the ostomy market only grows in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results